Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

Bristol Myers Squibb logo

FDA starts priority review of BMS Opdivo/Yervoy in first-line NSCLC

A verdict is expected to be delivered by 15 May

- PMLiVE

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer

If approved would become first targeted therapy for tumour type

- PMLiVE

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly paid $25m upfront on top of a $15m equity investment

- PMLiVE

Christie Anbar appointed global healthcare lead at Ruder Finn

Anbar will oversee the agency's entire healthcare business

- PMLiVE

RFA strengthens team with a host of hires and promotions

New hires coincide with continued growth

- PMLiVE

Keeping up the fight against HIV and using the lessons to tackle other threats

Danny Buckland interviews Gilead’s Mike Elliott

- PMLiVE

Kanga Health appoints new commercial director

Kellie Sharp brings almost two decades of experience to the role

Digital therapeutics and their impact on society

Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?

Blue Latitude Health

- PMLiVE

Healthanuary?

Whether you are taking part in Dry January, Veganuary, or any other health regime, just keep going!

Page & Page Health

- PMLiVE

AbbVie lauds head-to-head win for Skyrizi versus Cosentyx

Outperformed rival across all primary and secondary endpoints

- PMLiVE

Nektar’s opioid analgesic slammed with FDA panel rejection

Panelists unanimously rejected use of the chronic back pain drug

- PMLiVE

Congenica launches new application Congenica Neuro

Provides faster analysis of epilepsy and neurodevelopmental disorders

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links